Question

why did loreen ahern take tamoxifen during her breast cancer treatment?
to prevent brca mutation-induced ovarian and pancreatic cancers
to directly kill the breast cancer cells using targeted therapy
to reduce estrogen production and reduce the likelihood that mutations in breast cells will occur
to treat her secondary cancer that resulted from metastatic breast cancer

Explanation:

Tamoxifen is a selective estrogen receptor modulator. It works by binding to estrogen receptors in breast tissue, blocking estrogen from binding to these receptors. This reduces the effects of estrogen on breast cells. Since estrogen can promote the growth of some breast cancer cells (especially in estrogen - receptor - positive breast cancers), reducing estrogen's influence on breast cells can reduce the likelihood of mutations and growth of cancerous breast cells.

• Option A: Tamoxifen is not used to prevent BRCA mutation - induced ovarian and pancreatic cancers. BRCA - related ovarian cancer prevention may involve other strategies like prophylactic oophorectomy in some cases.
• Option B: Tamoxifen does not directly kill breast cancer cells. Chemotherapy drugs are more likely to have a direct cytotoxic effect on cancer cells.
• Option D: Tamoxifen is mainly used in the treatment of primary breast cancer (especially estrogen - receptor - positive types) and for reducing the risk of recurrence, not specifically for treating secondary cancers resulting from metastatic breast cancer (although it may be used in some metastatic cases if the cancer is estrogen - receptor - positive).

Answer:

C. to reduce estrogen production and reduce the likelihood that mutations in breast cells will occur